politics

technology

sports

health

other

Actress Kanchan Awasthi Appointed Brand Ambassador for Avon Scooty

Mumbai, 10 October, 2025: After a grandly successful association with
Avon Cycles, popular film and television actress Kanchan Awasthi is now
set to represent the brand’s next milestone — as the Brand Ambassador
for Avon Scooty.

This renewed collaboration marks an exciting new
phase in Kanchan’s partnership with the iconic Avon brand, symbolizing
modern mobility, style, and empowerment. Avon Scooty, known for its
innovative, eco-friendly, and affordable two-wheelers, has chosen
Kanchan Awasthi to embody its vision of freedom and confidence for
today’s generation.

The new advertisement campaign, recently shot
with Kanchan, showcases her beautiful smile and infectious energy as
she rides the latest Avon Scooty models with effortless charm. The
visuals perfectly capture the spirit of a self-made woman who represents
modern girl power — confident, independent, and inspiring.

Expressing
her enthusiasm, Kanchan Awasthi said, “It’s a pleasure to continue my
journey with the Avon family, this time as the face of Avon Scooty.
Two-wheelers, especially scooters, have become symbols of freedom and
self-reliance, especially for women. I truly believe in promoting
convenient and eco-friendly ways of commuting, and Avon Scooty perfectly
represents that spirit. I’m excited to inspire more people to ride
towards independence and sustainability.”

The association between
Kanchan Awasthi and Avon Scooty is expected to amplify the brand’s
outreach, connecting with youth, women, and urban commuters who value
style with purpose. Following the success of the Avon Cycles campaign,
this partnership continues to highlight Avon’s commitment to offering
mobility solutions that are both progressive and planet-friendly.

With
Kanchan Awasthi as the face of Avon Scooty, the brand aims to redefine
everyday commuting — merging performance, affordability, and
environmental consciousness — all with a touch of glamour and
empowerment.

 

Mumbai, October 6, 2025 (SCNWire)— Mahindra & Mahindra Ltd., India’s leading SUV manufacturer, has introduced an all-new range of its iconic Bolero lineup. The updated models — including the refreshed Bolero and Bolero Neo — come with bold design changes, upgraded interiors, and modern technology. Prices start at ₹7.99 lakh (ex-showroom) for the New Bolero and ₹8.49 lakh for the Bolero Neo, with top-end variants priced at ₹9.69 lakh and ₹9.99 lakh respectively.

With a strong legacy of over 25 years and more than 16 lakh units sold, the Bolero continues to be a symbol of reliability and ruggedness, especially across India’s diverse terrains. The latest updates aim to retain its core DNA while aligning with the evolving aspirations of today’s SUV buyers.

New Bolero: Bolder, Smarter, and More Comfortable

The New Bolero now wears a sharper look with a redesigned grille, new fog lamps, and stylish diamond-cut R15 alloy wheels. A striking new “Stealth Black” paint option joins the familiar palette of Diamond White, DSAT Silver, and Rocky Beige.

Inside, Mahindra has enhanced comfort with newly contoured seats finished in premium leatherette. A 17.8 cm touchscreen infotainment system with steering-mounted audio controls brings modern convenience to the cabin. The addition of RideFlo technology further improves driving dynamics, enhancing ride comfort and stability across varied road conditions.

Under the hood, the New Bolero continues to be powered by the robust mHAWK75 engine, delivering 55.9 kW of power and 210 Nm of torque, paired with a durable body-on-frame chassis.

New Bolero Neo: Rugged Meets Urban Refinement

Catering to young, ambitious urban and semi-urban buyers, the New Bolero Neo blends ruggedness with sophistication. A sleeker grille, new colour options like Jeans Blue and Concrete Grey, and stylish R16 dark metallic grey alloy wheels give it a more urban appeal.

The interiors feature new theme options — Lunar Grey and Mocha Brown — with leatherette upholstery. The 22.8 cm touchscreen infotainment system is complemented by a rear-view camera and USB C-type port for added tech convenience. RideFlo, paired with MTV-CL and Frequency Dependent Damping (FDD) suspension, ensures a smoother and more controlled ride.

The Bolero Neo is powered by the mHAWK100 engine, offering 73.5 kW of power and 260 Nm of torque. Advanced features like cruise control and Multi-Terrain Technology (MTT) with a locking differential enhance off-road capability.

Pricing and Variant Breakdown

New Bolero (Ex-Showroom Prices):

  • B4: ₹7.99 lakh

  • B6: ₹8.69 lakh

  • B6(O): ₹9.09 lakh

  • B8: ₹9.69 lakh

New Bolero Neo (Ex-Showroom Prices):

  • N4: ₹8.49 lakh

  • N8: ₹9.29 lakh

  • N10*: ₹9.79 lakh

  • N11: ₹9.99 lakh

    (*N10 optional variant with additional features)

Mahindra’s latest updates to the Bolero and Bolero Neo reaffirm its commitment to delivering value-driven, tough-yet-comfortable SUVs. As India’s SUV market continues to evolve, the new Bolero range positions itself as a dependable choice for buyers seeking a blend of legacy ruggedness and contemporary refinement — whether on busy urban roads or challenging rural trails.
– SCNWire

 




New Delhi [India], October 6: Australia is consistently among the world’s top study destinations — a powerful combination of high-quality universities, industry-linked curriculum, a multicultural student community and clear post-study pathways. Azent’s Priyanka Nishar (Founder & Managing Director) explains what sets Australia apart and the holistic experience it offers which makes Australia an excellent choice for graduate study.


1. What makes Australia a premier destination?

Several factors set Australia apart. Its universities regularly appear in global rankings and are renowned for research, teaching quality and international outlook — making degrees from Australia highly respected worldwide. Major research universities such as the University of Melbourne, ANU, UNSW, Monash and the University of Queensland feature in top global lists.

Beyond rankings, Australia offers:

  • Strong industry connections and work-integrated learning (internships, industry projects and placements) that improve employability.

  • Jobs and Skills Australia

  • A safe, multicultural society and vibrant student life across cities like Melbourne, Sydney, Brisbane and Perth.

  • Transparent student supports (counselling, career services) and regulated education standards overseen by government bodies.

  • Work rights for student visa holders (limited working hours during study, with pathways after graduation to live and work temporarily).

2. What are some recommended courses and universities for graduate study?

Which course is “best” depends on your career goals, but in 2025 the highest-demand sectors and popular graduate programs include:

  • Information Technology & Data Science (AI, cybersecurity, data analytics) — strong industry demand and many universities offer specialist master’s programs.

  • Engineering & Built Environment (civil, electrical, software, environmental engineering).

  • Health & Allied Health (nursing, public health, physiotherapy) — very strong demand across states.

  • Business & Management (MBA, specialized management) — wide employer networks and internships.

  • Research degrees (MPhil/PhD) for those pursuing academic or R&D careers.

For institutional reputation and research strength, consider the Group of Eight (research-intensive) and other top-ranked universities: University of Melbourne, ANU, UNSW Sydney, University of Sydney, Monash University, University of Queensland and others. Each has distinct strengths by faculty and subject area, so match your discipline to the university’s subject ranking and industry links. Degrees earned here are recognised worldwide, giving graduates an edge in competitive job markets back home or elsewhere abroad.

But academic ranking tells only part of the story. Students are drawn to Australia’s clear emphasis on practical, industry-linked education. Many master’s and professional programs incorporate internships, research partnerships and work-integrated learning, ensuring that graduates are not just well-read but also work-ready. This close connection to industry has been particularly beneficial in areas like IT, data science, healthcare and engineering — sectors where Australian employers face acute skill shortages and actively seek qualified professionals.


3. Briefly take us through the admissions process and fee structure?

The road to admission is straightforward but competitive. Most master’s programs require a relevant undergraduate degree with solid academic performance.

•⁠ Choose course & university: shortlist programs by curriculum, industry tie-ups, location and scholarships.

•⁠ Check entry requirements: most master’s programs ask for a relevant bachelor’s degree (or equivalent) and a competitive GPA; some professional programs require work experience (e.g., MBA).

•⁠ ⁠English proficiency: IELTS, TOEFL or PTE scores are commonly required; minimums vary by program.

•⁠ Documents: transcripts, CV, statement of purpose, references, portfolio (for creative courses) and any professional certificates.

•⁠ ⁠⁠The Genuine Student (GS) assessment must be cleared with the university, which includes successfully completing the university interview and meeting the financial requirements.

•⁠ Apply online via each university’s portal. If accepted, the university will issue an Offer Letter, and once you accept it, clear a genuine student assessment, and pay the deposit, a Confirmation of Enrolment (CoE) will be issued

Fee structure

International master’s tuition in Australia commonly ranges from ~AUD 22,000 to AUD 50,000 per year, depending on discipline and university; professional degrees (e.g., MBA, medicine, dentistry) can be higher. Living costs vary by city — Sydney and Melbourne are usually pricier than regional cities.


4. What are the visa and pre-arrival costs?

To obtain a student visa you’ll need proof of financial capacity. Recent government guidance requires applicants to show minimum savings (commonly quoted around A$29,710 as a baseline for living costs), though amounts and evidentiary requirements can change — confirm the latest Home Affairs guidance before applying. You must also purchase Overseas Student Health Cover (OSHC) for the duration of your stay unless exempt.


5. Explain the work prospects in Australia?

Work opportunities, however, make Australia particularly appealing. International students are permitted to work part-time during their studies, traditionally capped at 48 hours per fortnight. This allows them to offset living expenses and gain local work experience. More importantly, after completing their degrees, graduates may be eligible for a Temporary Graduate visa, which allows them to live and work in Australia for a defined period. The duration depends on the qualification obtained and government policy settings, but it provides valuable time to gain international work experience and, in some cases, explore pathways to longer-term residence.


6. How can Azent help prospective students?

Azent has carved a niche for itself by going beyond traditional consultancy services, providing unwavering commitment to student success, through its innovative approach, and personalized services. We offer a wide range of services tailored to meet the diverse needs of students. At its state-of-the-art experience centres & virtual centres across India, students not only get end-to-end support with application, admissions, visas, loans, but can also experience college campuses through Virtual Reality

Additionally, with our Azent App students can build their profile, narrow down universities, get recommendations based on their profile, complete and track the applications and do much more. Prospective students can also avail Azent’s best-in-class training for IELTS at affordable costs.

Azent’s partnerships cover 1500+ Universities across the world to improve student recruitment and match them with the top talent that would thrive in their programs.

Prospective students can log on to https://www.azent.com / or download the Azent App to avail our best-in-class counselling services.

A fresh design, unmatched power, and timeless legacy. Thar fans, stay excited – another Thar is coming your way!

Raj Vehicles, Mohali proudly hosted the press conference to unveil the much-awaited New Mahindra Thar. With a refreshed design, advanced comfort, and enhanced smart connectivity, the New Thar sets a new benchmark in the SUV segment.

Starting at an attractive price of ₹9.99 lakh, the new model embodies both adventure and sophistication, making it ideal for urban commuting as well as off-road exploration. Adding to the event’s charm, renowned personality Arvinder Kaur also graced the occasion as a special guest, making the unveiling even more memorable.

The latest Thar boasts a distinctive new look, including a bold dual-tone front bumper, redesigned dashboard, all-black theme interiors, and six exciting color options such as Tango Red and Battleship Grey. Comfort has been elevated with a new center console featuring sliding armrest, rear AC vents, and door-mounted power windows.

Smart technology plays a central role, with a 26.03 cm HD infotainment system supporting Android Auto and Apple CarPlay, Adventure Stats Gen II, and Type-C USB ports, ensuring seamless connectivity for today’s generation.

Mr. Rajvinder Singh, MD of Raj Vehicles, expressed enthusiasm about this launch, stating, it was highlighted that the New Thar is not just a vehicle but a symbol of freedom, lifestyle, and exploration. Its enhanced design, cutting-edge tech, and unmatched capability will inspire generations to embrace adventure and redefine driving experiences.

With this launch, Raj Vehicles reaffirms its commitment to bringing innovative and customer-centric products to the Punjab market.

 


The Floor Price is 31.0 times the face value of Equity Shares and the Cap Price is 32.6 times the face value of the Equity Shares.

Bid / Offer will open on Monday, October 6, 2025 and close on Wednesday, October 8, 2025 (“Bid Dates”).

The Anchor Investor Bid / Offer Period shall be Friday, October 3, 2025.

Bids can be made for a minimum of 46 Equity Shares and in multiples of 46 Equity Shares thereafter. (“No. of Bids”)

Red Herring Prospectus link: https://investmentbank.kotak.com/downloads/tatacapital-RHP.pdf

National, October 04, 2025: Tata Capital Limited (“TCL” or the “Company”), shall open the  Bid/Offer in relation to its initial public offer of Equity Shares on Monday, October 6, 2025.

The Price Band of the Offer has been fixed at ₹ 310 to ₹ 326 per Equity Share. (“Price Band”). Bids can be made for a minimum of 46 Equity Shares and in multiples of 46 Equity Shares thereafter. 

The initial public offer comprises of offer of up to 475,824,280 Equity Shares (“Total Offer Size”) comprising of a fresh issue of up to 210,000,000 Equity Shares (“Fresh Issue”) and an offer for sale of up to 265,824,280 Equity Shares (“Offer for Sale”).

The selling shareholders are Tata Sons Private Limited (the “Promoter Selling Shareholder”) selling up to 230,000,000 Equity Shares and International Finance Corporation (the “Investor Selling Shareholder”) selling up to 35,824,280 Equity Shares.

The Anchor Investor Bidding Date shall be Friday, October 3, 2025, and the Bid/Offer shall close on Wednesday, October 8, 2025.

The Company proposes to utilize the net proceeds from the Fresh Issue towards augmenting its Tier-I capital base to meet the Company’s future capital requirements, including onward lending (the “Object of the Offer”).

The Equity Shares are being offered through the red herring prospectus of the Company dated September 26, 2025 (the “Red Herring Prospectus”), filed with the Registrar of Companies, Maharashtra at Mumbai (the “ROC”). The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on BSE Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”).

Kotak Mahindra Capital Company Limited,  Axis Capital Limited, BNP Paribas, Citigroup Global Markets India Private Limited, HDFC Bank Limited, HSBC Securities and Capital Markets (India) Private Limited, ICICI Securities Limited, IIFL Capital Services Limited (formerly known as IIFL Securities Limited), J.P. Morgan India Private Limited, and SBI Capital Markets Limited are the book running lead managers to the Offer (the “BRLMs”).

All capitalised terms used herein but not defined shall have the same meaning as ascribed to them in the Red Herring Prospectus.

The Offer is being made in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (the “SCRR”), read with Regulation 31 of the SEBI ICDR Regulations. The Offer is being made through the Book Building Process in accordance with Regulation 6(1) of the SEBI ICDR Regulations, wherein not more than 50% of the Net Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs” and such portion, the “QIB Portion”). The Company, in consultation with the BRLMs, may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis, in consultation with the BRLMs, in accordance with the SEBI ICDR Regulations (the “Anchor Investor Portion”).

One-third of the Anchor Investor Portion shall be reserved for domestic Mutual Funds, subject to valid Bids being received from the domestic Mutual Funds at or above the price at which allocation is made to Anchor Investors (“Anchor Investor Allocation Price”). In the event of under-subscription, or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the QIB Portion (excluding the Anchor Investor Portion) (“Net QIB Portion”). 

Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received from them at or above the Offer Price. However, if the aggregate demand from Mutual Funds is less than 5% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. 

Further, not less than 15% of the Net Offer shall be available for allocation on a proportionate basis to Non-Institutional Investors (“Non-Institutional Portion”) (of which one-third shall be available for allocation to Bidders with an application size of more than ₹0.2 million and up to ₹1.0 million and two-thirds shall be available for allocation to Bidders with an application size of more than ₹1.0 million, provided that the unsubscribed portion in either of such sub-categories may be allocated to Bidders in the other sub-category of Non-Institutional Portion subject to valid Bids being received at or above the Offer Price) and not less than 35% of the Net Offer shall be available for allocation to Retail Individual Investors (“Retail Portion”) in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price.

All potential Bidders (except Anchor Investors) are required to mandatorily utilise the Application Supported by Blocked Amount (“ASBA”) process by providing details of their respective ASBA Accounts (as defined hereinafter), and UPI ID in case of UPI Bidders (as defined hereinafter) using the UPI Mechanism, if applicable, in which the corresponding Bid Amounts will be blocked by the Self Certified Syndicate Banks (“SCSBs”) or under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors are not permitted to participate in the Offer through the ASBA process. For details, see “Offer Procedure” on page 759 of the Red Herring Prospectus.

 


New Delhi [India], October 2 : October is globally observed as Breast Cancer Awareness Month, a time when the pink ribbon takes over cityscapes, workplaces, and social media feeds. But behind the symbolism lies an urgent question for India: Are we doing enough to address breast cancer not just through treatment, but through prevention?

According to the Indian Council of Medical Research (ICMR), breast cancer has now overtaken cervical cancer as the most common cancer among Indian women. What’s equally alarming is its increasing prevalence among younger women, many of them mothers balancing careers, caregiving, and personal health.

This is where nutrition quietly steps in as an overlooked, yet powerful shield. Emerging research points to the role of balanced diets rich in fiber, antioxidants, plant-based proteins, and essential micronutrients in lowering cancer risks. For mothers, who often shape the family’s food habits, the impact of such choices goes beyond their own health—it influences their children’s long-term well-being too.


The Science of Prevention: A Nutritious Approach

Prevention is not just about annual check-ups. It begins every day at the dining table. When mothers choose clean, nutrient-dense foods, they aren’t just reducing their own risks—they’re shaping the health trajectory of the next generation. A diet rich in the following can be particularly protective:

  • Fiber: Found in whole grains, fruits, vegetables, and legumes, fiber helps regulate hormones and remove toxins from the body.

  • Antioxidants: These powerful compounds, abundant in colorful fruits and vegetables (e.g., berries, spinach, and bell peppers), combat cellular damage caused by free radicals, which can lead to cancer development.

  • Plant-based proteins: Choosing plant-based proteins over red and processed meats can lower cancer risk. Lentils, chickpeas, tofu, and nuts are excellent sources.

  • Essential micronutrients: Vitamins and minerals like Vitamin D and calcium have been shown to play a role in reducing breast cancer risk.


Beyond Awareness: Toward a Pink Economy

The concept of an ‘India’s Pink Economy’ is emerging where awareness, healthcare, nutrition, and corporate social responsibility converge. Breast cancer awareness is no longer just a health issue; it is also a business opportunity to create meaningful impact.

As consumers increasingly demand wellness products with purpose, companies like Nutribray are finding themselves at the intersection of commerce and care. For every product designed for maternal and child nutrition, the brand is also investing in awareness campaigns and community nutrition education during Breast Cancer Awareness Month.

“Silent struggles like maternal mental health and overlooked risks like breast cancer need collective attention,” says the spokesperson. “Brands must step up, not only to provide healthier options but also to spark conversations that change how India thinks about prevention.”


The Way Forward

As India grapples with rising cancer numbers and maternal health challenges, the conversation must shift from cure to care, from treatment to prevention. Nutrition is not the silver bullet, but it is the first shield—one that is affordable, accessible, and profoundly influential.

In the words of public health experts: “A mother nourishes a family. If we protect her, we protect everyone.”

This October, as the pink ribbons flutter across cities, perhaps it’s time to see the color not just as a symbol of awareness, but as a reminder of something deeper—that prevention begins on our plate, and mothers are leading the way.


 



The luxury aesthetic center, founded by Emirati entrepreneur Khaled Al Harmoudi, wins “Best Clinic” and “Best Customer Service” for its revolutionary treatments and unparalleled patient experience.



DUBAI [UAE] : In a significant achievement solidifying its position in Dubai’s competitive luxury wellness landscape, Dynasty Clinic has been honored with two of the industry’s most coveted accolades: the Best Clinic Award and the Best Customer Service Award. These prestigious recognitions celebrate the clinic’s visionary mission to redefine the standards of care, trust, and luxury for a global clientele.

The clinic’s success is a direct reflection of a patient-centric philosophy that has made it the destination of choice for a discerning international elite, including prominent actors, models, and high-profile figures. These clients are consistently drawn to Dynasty Clinic for its team of world-renowned doctors and an impeccable standard of care that prioritises both results and discretion.

“These awards are a profound honor and a direct reflection of the trust our clients place in us,” said Khaled Al Harmoudi, Founder of Dynasty Clinic. “My vision was to build a sanctuary where science, artistry, and personalized care converge to empower our clients. To have that mission recognised by the industry is incredibly rewarding for our entire team.”

The Entrepreneur’s Journey

The ascent of Dynasty Clinic is rooted in the inspiring personal journey of its founder. After seven years as a project engineer in the demanding oil and gas industry, Khaled Al Harmoudi made the courageous decision to leave his high-stakes career in 2021 to pursue a more meaningful path.

“I realised I couldn’t have a full-time job and run a clinic that requires more than eight hours of my day,” Al Harmoudi explains. This transition from engineering to a full-time clinic owner laid the foundation for a business built on passion and a deep commitment to excellence.

A Hub of Medical Innovation

At the core of Dynasty Clinic’s acclaim is its mastery of cutting-edge services that have earned it international recognition. The clinic specialises in several advanced treatments:

  1. Stem Cell Therapy: As a pioneer in regenerative medicine, the clinic harnesses the body’s natural healing abilities for powerful anti-ageing, skin rejuvenation, and overall vitality.

  2. EBOO Therapy: A globally trending wellness treatment, EBOO (Extracorporeal Blood Oxygenation and Ozonation) therapy purifies the blood and revitalises the body at a cellular level, making it a cornerstone of preventative health for clients seeking peak performance and a vibrant appearance.

  3. Endo Lift: This groundbreaking, minimally invasive laser treatment offers a non-surgical solution for skin tightening, sculpting facial contours, and restoring a natural, youthful firmness without the downtime of traditional surgery.

  4. Therapeutic Plasma Exchange (TPE): Offering this sophisticated medical procedure for complex health conditions, the clinic showcases its capacity to handle advanced treatments with exceptional skill, positioning itself as a comprehensive healthcare destination.

The Best Clinic and Best Customer Service Awards are more than public recognition; they are a testament to the visionary journey of Khaled Al Harmoudi and the entire Dynasty Clinic team as they continue to set the benchmark for luxury healthcare in Dubai and beyond.

About Dynasty Clinic

Dynasty Clinic is a premier aesthetic and wellness center located in the heart of Dubai, renowned for its luxurious atmosphere and world-class service. Catering to a discerning global clientele that includes renowned actors and models, the clinic is staffed by internationally recognized aesthetic specialists. Dynasty Clinic is committed to excellence, utilizing only the highest quality imported medical products and state-of-the-art equipment. It offers a curated selection of advanced, evidence-based treatments designed to enhance beauty and promote holistic well-being, ensuring a private, effective, and highly personalized experience for every client.

Contact Information: Dynasty Clinic Address
Villa 159, Umm Al Sheif Rd – Al Safa 2 – Dubai | Phone: 04 330 0048




28th Globoil India Summit 2025 Concludes in Mumbai with Record Global Participation


Mumbai (Maharashtra) [India], September 29:  The 28th edition of Globoil India Summit 2025 was organised by Tefla in Mumbai. This three-day event (September 24–26) successfully brought together over 2,000 delegates from 60+ countries, reinforcing its reputation as the “Olympics of the edible oil trade.”

With the theme “Future-Proofing the Edible Oil Industry: Smart Solutions for Volatile Markets,” the summit featured thought-provoking discussions, business opportunities, and cultural showcases. Gapki was the country partner for the event. Distinguished speakers including YB Datuk Seri Johari Bin Abdul Ghani (Malaysia’s Plantation & Commodities Minister), Eddy Martono (GAPKI Chairman), Dr. John Baffes (World Bank), Thomas Mielke (Oil World), Mdm. Izzana Salleh (Council of Palm Oil Producing Countries – CPOPC, Secretary General), Sandeep Bhan (SD Guthrie International Trading Pte. Ltd, CEO) and industry leaders from Godrej, Patanjali Foods, Emami Agrotech, AWL Agri, and N.K. Proteins, shared perspectives on market volatility, sustainable sourcing, biofuels, health & nutrition, and technology adoption.


The event also witnessed active participation from global partners such as the Indonesian Palm Oil Association (GAPKI), Roundtable on Sustainable Palm Oil (RSPO), and Patanjali Foods Ltd. The exhibition, featuring 80+ companies, showcased cutting-edge refining technologies, packaging solutions, and innovative edible oil products. Deals worth hundreds of millions of dollars were initiated, highlighting Globoil’s role as a leading trade and networking hub.

Beyond business, delegates enjoyed the Gala Networking Dinner and cultural evenings, reflecting India’s rich traditions while fostering global partnerships. Actresses Bhagyashree and Vaani Kapoor graced the evening reception at The Westin Mumbai Powai Lake. The programme featured a special musical set by singers Farid Ahmed and Babbar Mudasar, along with an International Dance and Fashion Show, adding vibrancy to the summit experience.


Speaking at the event, Mr Aadil Singh, Director of Tefla’s, said: “Globoil India once again proved to be a world-class platform for dialogue, collaboration, and deal-making. This year’s emphasis on sustainability and innovation will shape the edible oil industry for years to come.”

Globoil is a Premier International Conference & Exhibition on Vegetable Oil, Feed & Feed Ingredients, Oilseeds & Oleochemicals organised by Tefla’s under the patronage of The Solvent Extractors’ Association of India.

Kindly visit the website www.globoilindia.com for more information.

Dear Government Lottery Celebrates Rs. 3 Crore ticket win with Felicitation Ceremony, Mushtaq Khan Honours Stockist and Seller

The festive spirit of Ganesh Chaturthi shone brighter this year as Dear Lottery, India’s leading government-backed lottery, hosted a grand felicitation ceremony at Sadguru krupa Lottery Centre, Mazgaon, Mumbai Dockyard Road, to honour the Retailer and Stockist of the Dear Ganesh Chaturthi Bumper Lottery 2025.

The highlight of the ceremony was the felicitation of the ₹3 Crore 1st Prize seller, celebrated alongside the stockist and seller who played a pivotal role in the winning ticket’s journey. The winning ticket, No. 158279, was drawn on September 20, 2025, Draw No. 1 at 8.00 PM, under the Sikkim State Lotteries Dear Ganesh Chaturthi Bumper Lottery.

The ticket was sold by Sadguru Lottery, Mazgaon, Maharashtra, which earned the Seller Prize Amount of ₹25 Lakhs. Ganesh Enterprises, Dadar, Mumbai, the proud stockist received the Stockist Prize Amount of ₹10 Lakhs. Together, they were felicitated for their integral role in bringing fortune to the 1st prize winner of ₹3 Crores.

The daytime celebration witnessed the gracious presence of veteran actor Mushtaq Khan, who felicitated the stockist and seller, adding a touch of warmth and stardom to the proceedings. Mushtaq Khan has also been associated with the Sikkim State Dear Ganesh Chaturthi Bumper Lottery campaign, directed by Mohsin Khan.

Speaking on the occasion, Mushtaq Khan said: “I love meeting people whose lives change with such life-altering moments. Seeing their smiles and the happiness it brings to their families is a truly heartwarming experience. I am delighted to felicitate them and share in their joy today.”

Also present at the celebration were Mr. Rajesh Madan and Mr. Anand Mavani from Dear Lottery, who jointly expressed their gratitude and optimism for the continued success of Dear Lottery. They said: “At Dear Lottery, we are committed to creating life-changing opportunities for people, while ensuring transparency and trust. The Sikkim State Dear Ganesh Chaturthi Bumper Lottery is a shining example of how festive cheer can translate into fortune, not only for the winner but also for our hardworking sellers and stockists. We extend our heartfelt congratulations to the 1st Prize seller, Sadguru Krupa Lottery Centre and Ganesh Enterprises, Dadar, Mumbai, for being an integral part of this historic moment.”

Dear Lottery is the leading player in India’s lottery industry. Since its inception in 1991, it has built a robust network of dealers, stockists, and agents across multiple states where lottery sales are permitted. The company has consistently retained its leadership position through competitive bidding, aggressive marketing, and efficient operations.

By distributing traditional paper lotteries of various state governments, Dear Lottery has become synonymous with trust and innovation. Its focus on transparency, consumer satisfaction, and continual market research has made it a household name in India. With every ticket sold, Dear Lottery continues its mission to bring prosperity, joy, and hope to millions.

The Sikkim State Dear Ganesh Chaturthi Bumper Lottery 2025 Felicitation at Mazgaon, Mumbai, will be remembered not just for celebrating a ₹3 Crore win but also for highlighting the values of trust, opportunity, and festivity that define Dear Lottery.


 

Hyderabad (Telangana) [India] : Reinforcing the Government of India’s mission to provide equitable healthcare, Hetero Healthcare Limited, in partnership with Enzene Biosciences, has launched Perzea, its most affordable biosimilar Pertuzumab for HER2-positive breast cancer. This initiative underlines the critical need for advanced cancer treatment accessibility in the country.

Closing the Treatment Gap
Pertuzumab, a globally accepted monoclonal antibody therapy, significantly improves outcomes when used with trastuzumab and chemotherapy. However, for many Indian patients, high costs have been a deterrent. Perzea bridges this divide, offering patients a more affordable yet effective option.

“Hetero Healthcare is proud to support the nation’s healthcare goals,” said Mr. M. Srinivas Reddy, Managing Director. “Perzea represents our responsibility to provide Indian patients with world-class therapies at a fraction of global costs.

Strengthening Oncology Access in India
This launch also reflects India’s growing role as a hub for biosimilar development. By collaborating with Enzene Biosciences, Hetero Healthcare demonstrates how partnerships can combine science, scale, and affordability to improve patient outcomes.

About Hetero Healthcare
Hetero Healthcare Limited has been a leader in oncology, antiretrovirals, and critical care therapies. Its mission to deliver affordable healthcare solutions across India continues to make a profound impact on millions of lives. More: www.heterohealthcare.com

About Enzene Biosciences
Enzene is advancing biologics manufacturing through its EnzeneX™ technology, aiming to reduce monoclonal antibody production costs significantly. Its focus on innovation and efficiency supports global access to critical therapies. More: www.enzene.com

Disclaimer: This article is for general information purposes only and should not be construed as professional medical advice. Always consult your doctor before taking any step.